Annual Revenue
N/A
December 31, 2022
Summary
- ACER annual revenue is not available.
Performance
ACER Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Revenue
N/A
June 30, 2023
Summary
- ACER quarterly revenue is not available.
Performance
ACER Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM Revenue
N/A
June 30, 2023
Summary
- ACER TTM revenue is not available.
Performance
ACER TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
ACER Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
ACER Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time |
Acer Therapeutics Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | $1.26 M(-56.6%) | $360.00 K(-60.0%) | $1.26 M(+40.0%) |
| Mar 2021 | - | $900.00 K(+23.9%) | $900.00 K(-69.0%) |
| Dec 2016 | $2.91 M(+13.6%) | $726.30 K(0.0%) | $2.91 M(0.0%) |
| Sep 2016 | - | $726.30 K(0.0%) | $2.91 M(0.0%) |
| Jun 2016 | - | $726.30 K(0.0%) | $2.91 M(0.0%) |
| Mar 2016 | - | $726.30 K(0.0%) | $2.91 M(+13.6%) |
| Dec 2015 | $2.56 M(+101.0%) | $726.30 K(0.0%) | $2.56 M(+19.6%) |
| Sep 2015 | - | $726.30 K(0.0%) | $2.14 M(+24.3%) |
| Jun 2015 | - | $726.30 K(+92.4%) | $1.72 M(+32.2%) |
| Mar 2015 | - | $377.50 K(+22.7%) | $1.30 M(+2.3%) |
| Dec 2014 | $1.27 M(+0.4%) | $307.70 K(0.0%) | $1.27 M(-3.1%) |
| Sep 2014 | - | $307.70 K(0.0%) | $1.31 M(-3.0%) |
| Jun 2014 | - | $307.70 K(-11.8%) | $1.35 M(-2.9%) |
| Mar 2014 | - | $348.80 K(0.0%) | $1.40 M(+10.2%) |
| Dec 2013 | $1.27 M(>+9900.0%) | $348.80 K(0.0%) | $1.27 M(+38.0%) |
| Sep 2013 | - | $348.80 K(0.0%) | $917.70 K(+61.3%) |
| Jun 2013 | - | $348.80 K(+58.5%) | $568.90 K(+158.5%) |
| Mar 2013 | - | $220.10 K | $220.10 K |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2003 | $3900.00(-75.8%) | - | - |
| Mar 2003 | - | $2600.00(+766.7%) | $4000.00(-75.2%) |
| Sep 2002 | $16.10 K(-93.5%) | $300.00(-72.7%) | $16.10 K(-134.0%) |
| Jun 2002 | - | $1100.00(-85.5%) | -$47.40 K(+207.8%) |
| Mar 2002 | - | $7600.00(+7.0%) | -$15.40 K(-122.1%) |
| Dec 2001 | - | $7100.00(-111.2%) | $69.80 K(-72.0%) |
| Sep 2001 | $249.60 K(-69.4%) | -$63.20 K(-290.9%) | $249.60 K(-51.7%) |
| Jun 2001 | - | $33.10 K(-64.3%) | $516.50 K(-25.7%) |
| Mar 2001 | - | $92.80 K(-50.3%) | $695.50 K(-8.8%) |
| Dec 2000 | - | $186.90 K(-8.2%) | $763.00 K(-7.7%) |
| Sep 2000 | $816.20 K(-71.9%) | $203.70 K(-4.0%) | $826.90 K(-0.6%) |
| Jun 2000 | - | $212.10 K(+32.3%) | $831.90 K(-47.2%) |
| Mar 2000 | - | $160.30 K(-36.1%) | $1.57 M(-26.9%) |
| Dec 1999 | - | $250.80 K(+20.2%) | $2.15 M(-25.7%) |
| Sep 1999 | $2.90 M | $208.70 K(-78.2%) | $2.90 M(+7.7%) |
| Jun 1999 | - | $955.20 K(+29.0%) | $2.69 M(+55.0%) |
| Mar 1999 | - | $740.20 K(-25.8%) | $1.74 M(+74.2%) |
| Dec 1998 | - | $997.70 K | $997.70 K |
FAQ
- What is the all time high annual revenue for Acer Therapeutics?
- What is the all time high quarterly revenue for Acer Therapeutics?
- What is the all time high TTM revenue for Acer Therapeutics?
What is the all time high annual revenue for Acer Therapeutics?
Acer Therapeutics all-time high annual revenue is $2.91 M
What is the all time high quarterly revenue for Acer Therapeutics?
Acer Therapeutics all-time high quarterly revenue is $997.70 K
What is the all time high TTM revenue for Acer Therapeutics?
Acer Therapeutics all-time high TTM revenue is $2.91 M